We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

SPRB Spruce Biosciences Inc

0.03 (1.32%)
Last Updated: 14:05:04
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 7,252
Bid Price 2.25
Ask Price 2.28
News -
Day High 2.33


52 Week Range


Day Low 2.26
Company Name Stock Ticker Symbol Market Type
Spruce Biosciences Inc SPRB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 1.32% 2.30 14:05:04
Open Price Low Price High Price Close Price Prev Close
2.31 2.26 2.33 2.27
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
87 7,252 $ 2.30 $ 16,711 - 0.9547 - 3.57
Last Trade Time Type Quantity Stock Price Currency
14:05:12 58 $ 2.25 USD

Spruce Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
93.63M 40.71M - 0 -46.18M -1.13 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Spruce Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SPRB Message Board. Create One! See More Posts on SPRB Message Board See More Message Board Posts

Historical SPRB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.432.512.252.3628,001-0.13-5.35%
1 Month2.252.752.14252.44119,6800.052.22%
3 Months2.122.752.002.3473,6290.188.49%
6 Months2.262.751.902.29118,9520.041.77%
1 Year1.373.570.95472.36453,2780.9367.88%
3 Years17.0035.600.95474.26537,980-14.70-86.47%
5 Years17.0035.600.95474.26537,980-14.70-86.47%

Spruce Biosciences Description

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Your Recent History
Spruce Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230927 18:26:13